Sassicaia Capital Advisers LLC Mustang Bio, Inc. Call Options Transaction History
Sassicaia Capital Advisers LLC
- $24.7 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MBIO
# of Institutions
2Shares Held
415KCall Options Held
0Put Options Held
0About MUSTANG BIO, INC.
- Ticker MBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,222,000
- Market Cap $24.2M
- Description
- Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...